Structural Analysis Reveals Mechanism of BIBR1532 Inhibition of Human Telomerase

Researchers have identified the structural interaction between human telomerase and the inhibitor BIBR1532, revealing how the compound blocks the enzyme’s activity. The study, published in *Nature Chemical Biology*, details the molecular mechanism of this inhibition, providing new data on how the drug binds to the telomerase complex.

The research team utilized structural analysis to map the specific binding site where BIBR1532 attaches to human telomerase. This interaction prevents the enzyme from performing its biological function, which involves maintaining the protective caps at the ends of chromosomes. By clarifying these structural details, the study documents the precise way the inhibitor interferes with the telomerase catalytic cycle. These findings offer a detailed look at the molecular architecture of the enzyme-inhibitor complex, providing a basis for further investigation into how such compounds interact with telomerase at a chemical level.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI